LOGICBIO THERAPEUTICS INC - COM (LOGC) Institutional Ownership

CUSIP: 54142F102

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2022

Type / Class
Equity / COM
Symbol
LOGC on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q4 0 $0 -$2,817,246 0
2022 Q3 10,338,612 $2,817,315 -$246,333 $0.27 26
2022 Q2 11,038,886 $3,877,403 -$595,945 $0.35 29
2022 Q1 12,720,713 $8,656,783 -$6,440,634 $0.68 34
2021 Q4 16,011,316 $36,995,531 -$2,265,108 $2.31 50
2021 Q3 15,989,024 $73,226,241 +$1,169,723 $4.58 52
2021 Q2 15,742,889 $69,897,379 -$11,145,284 $4.44 57
2021 Q1 17,627,010 $128,323,048 +$1,647,259 $7.28 58
2020 Q4 17,395,310 $132,729,192 +$50,673,431 $7.63 54
2020 Q3 10,734,910 $97,586,355 -$6,435,679 $9.08 47
2020 Q2 11,501,556 $97,668,562 +$2,810,965 $8.46 42
2020 Q1 11,172,726 $55,194,176 -$5,863,590 $4.94 41
2019 Q4 11,948,656 $86,027,518 -$9,001,788 $7.20 43
2019 Q3 12,808,010 $138,451,421 +$1,128,951 $10.81 40
2019 Q2 12,703,148 $165,137,519 +$3,034,047 $13.00 36
2019 Q1 12,580,316 $124,293,000 -$515,277 $9.88 32
2018 Q4 12,621,946 $131,266,000 +$131,265,997 $10.40 36